Published in Women's Health Weekly, August 1st, 2002
Franca Fruzzetti and colleagues at the University of Pisa performed an open, controlled clinical trial to determine the effects of naltrexone therapy on obese women with polycystic ovary syndrome (PCOS). The study involved 10 women who received 6 months of naltrexone (50 mg/day) therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly